Czech Republic Plans to Reduce Tobacco Harm with Nicotine Pouches

Jul.01.2022
Czech Republic Plans to Reduce Tobacco Harm with Nicotine Pouches
Czech Republic to implement a tobacco harm reduction strategy including the use of nicotine pouches, as local leadership attitudes change.

Due to a change in the mentality of local leaders, the Czech Republic will be implementing a strategy aimed at reducing the harm caused by tobacco, which includes the use of nicotine pouches. According to Ondřej Jakob, a spokesperson for the Czech Ministry of Health, a new action plan is currently being discussed and is expected to be implemented in the near future.

 

This issue has yet to be resolved. A new law is being prepared for nicotine pouches to define their composition, appearance, quality, characteristics, and other parameters, in order to minimize their adverse effects on human health." Jakob explained. The new law is expected to consider various factors that need to be taken into account. He said, "At this point, we anticipate debating a new action plan that should set the direction for the next three years, including tobacco addiction.

 

According to ECigIntelligence, successfully implementing harm reduction in the country's next three-year action plan could also promote other safer alternatives, such as electronic cigarettes and nasal snuff. Jakob discussed these products, stating that "electronic cigarettes and heated tobacco products are both controversial.

 

We believe that, in the future, new products should be designed with flavors that mask the unpleasant taste of nicotine while still adhering to harm reduction principles. However, they should be limited as much as possible to attract as few people as possible, especially young people, to avoid creating another batch of nicotine addicts.

 

The threat to teenagers, including risks to their health and the emergence of new addictions, has yet to be resolved and this may also apply to current non-smokers. For this reason, the Czech Republic is currently discussing this issue," he added.

 

The European Union is still spreading the "debunked theory".

 

Meanwhile, the EU Health and Food Safety Commissioner, Stella Kyriakides, questioned the effectiveness of e-cigarettes as a smoking cessation aid and even claimed that they are a gateway to smoking in another statement spreading misinformation about e-cigarettes.

 

Michael Landl, Director of the World Vapers' Alliance (WVA), expressed concern that the European Commission is still disregarding scientific evidence on e-cigarettes. He stated that it is alarming that the Commission continues to promote outdated and debunked theories on e-cigarettes, and systematically ignores vast amounts of scientific evidence that demonstrates their benefits, not to mention the firsthand experiences of millions of e-cigarette users. Compared to traditional therapies like gum or patches, e-cigarettes are 95% less harmful than smoking and a more effective method for quitting. The Commission's approach to e-cigarettes will only result in loss of life.

 

“Overall, it is known that both smokeless and novel tobacco and related products contain nicotine, a toxic and highly addictive substance known to be harmful to health - enhancing nicotine addiction. This is why these products are regulated and, as far as oral tobacco is concerned, banned by the European Union,” the statement concluded.

 

This article is compiled from third-party information sources, and the copyright of the compiled information belongs to the original media and author.

 


Disclaimer

This article is provided solely for professional research, industry discussion, and informational purposes. Any references to brands, companies, products, technologies, or policies are made for factual reporting and analytical purposes only, and do not constitute endorsement, recommendation, promotion, or advertising by 2Firsts.

Nicotine-containing products, including but not limited to cigarettes, e-cigarettes, heated tobacco products, and nicotine pouches, carry significant health risks. Readers are responsible for complying with all applicable laws and regulations in their respective jurisdictions, including age restrictions and access limitations.

The information contained in this article should not be regarded as investment, legal, medical, regulatory, or commercial advice. While 2Firsts strives to ensure the accuracy and reliability of its content, it does not assume liability for any direct or indirect loss arising from errors, omissions, inaccuracies, or reliance on the information contained herein.

This article is not intended for individuals below the legal age for accessing tobacco or nicotine-related information in their jurisdiction.

 

Copyright Notice

This article is either original content produced by 2Firsts or content reproduced, translated, summarized, or adapted from third-party sources with attribution where applicable. The intellectual property rights of the original content remain with 2Firsts or the respective original rights holders.

No individual or organization may copy, reproduce, distribute, republish, modify, translate, or otherwise use this content without prior authorization. Any unauthorized use may result in legal action.

For copyright-related inquiries, corrections, or removal requests, please contact: info@2firsts.com.

 

AI-Assisted Translation and Editing Notice

Portions of this article may have been translated, edited, or reviewed with the assistance of artificial intelligence tools to improve efficiency and readability. Due to the limitations of AI-assisted translation and editing, discrepancies, omissions, or inaccuracies may exist when compared with the original source.

Where applicable, readers are advised to refer to the original source for the most complete and accurate information. If you identify any errors or believe that any content infringes upon your rights, please contact us at info@2firsts.com, and we will review and address the matter promptly.

Ispire Reports Fiscal Q3 2026 Revenue of $18.7 Million and Net Loss of $9.5 Million
Ispire Reports Fiscal Q3 2026 Revenue of $18.7 Million and Net Loss of $9.5 Million
Ispire Technology reported financial results on May 7, 2026, for the third quarter of fiscal 2026, covering the three months ended March 31, 2026. Revenue was $18.7 million, compared with $26.2 million in the third quarter of fiscal 2025 and $20.3 million in the prior quarter. Gross profit was $2.0 million, with gross margin of 10.7%. Net loss was $9.5 million, or $0.17 per share. The company said it held $18.0 million in cash as of March 31, 2026, up $468,000 sequentially.
May.08 by 2FIRSTS.ai
FDA and IKE Tech Hold Formal Listening Session on Youth Access and Illicit ENDS Products
FDA and IKE Tech Hold Formal Listening Session on Youth Access and Illicit ENDS Products
U.S. Food and Drug Administration’s Center for Tobacco Products held a formal listening session with IKE Tech LLC to discuss youth prevention at the point of use for ENDS products, the circulation of illicit products in the supply chain, and the regulatory treatment of software in tobacco products.
Apr.10 by 2FIRSTS.ai
Nicotine Beyond Tobacco? Cell Study Signals Emerging Shift in Production Systems
Nicotine Beyond Tobacco? Cell Study Signals Emerging Shift in Production Systems
Researchers at the Chinese Academy of Sciences reconstructed nicotine biosynthesis in non-tobacco plants and yeast systems, highlighting how advances in synthetic biology could gradually reshape future nicotine production technologies and challenge regulatory frameworks built around tobacco-derived definitions.
Special Report
May.07
2Firsts Hosts UK Vape Duty Stamp Compliance Exchange in Shenzhen
2Firsts Hosts UK Vape Duty Stamp Compliance Exchange in Shenzhen
2Firsts held a UK vape duty stamp compliance exchange in Shenzhen on May 14, bringing together representatives from nearly 20 companies. The session addressed Vaping Products Duty, duty stamp applications, UK agency qualifications and warehousing, while introducing 2Firsts Compliance Solutions’ UK service.
Events
May.17
KT&G Overseas Tobacco Revenue Jumps 24.6%, Attracting Global Capital
KT&G Overseas Tobacco Revenue Jumps 24.6%, Attracting Global Capital
South Korean tobacco company KT&G is drawing growing global investor attention after reporting record overseas tobacco sales, with international institutions including Capital Group and BlackRock increasing their stakes.
Business
May.19
South Korea Moves Against Synthetic Nicotine Regulatory Gap as Three Companies Face Tobacco Business Act Probe
South Korea Moves Against Synthetic Nicotine Regulatory Gap as Three Companies Face Tobacco Business Act Probe
South Korea’s Ministry of Finance and Economy said on May 4 that it requested the Daejeon Metropolitan Police Agency and Gyeonggi Nambu Provincial Police Agency to investigate three sales companies on suspicion of violating the Tobacco Business Act.
May.06 by 2FIRSTS.ai